IP
App. : Application,
Reg. : Registration
| No. | Title of invention | Applicant | App./Reg. | App. number (Reg. number) |
App. date (Reg. date) |
|---|---|---|---|---|---|
| 1 | New peptide and pharmaceutical composition containing the same | Amyloid Solution Inc | KR App. | 10-2018-0147036 | 2018.11.29 |
| 2 | Pharmaceutical composition for treatment of neurodegenerative brain disease comprising triflupromazine or pharmaceutically acceptable salt thereof as an active ingredient | Amyloid Solution Inc | KR Reg. | 10-2019-0102680 (10-2051624) |
2019.08.21 (2019.11.26) |
| 3 | Pharmaceutical composition for treatment of neurodegenerative brain disease comprising rifamycin or pharmaceutically acceptable salt thereof as an active ingredient | Amyloid Solution Inc | KR Reg. | 10-2019-0152592 (10-2081785) |
2019.11.25 (2020.02.20) |
| 4 | Therapeutic composition and treatment method for amyloid neurological diseases | Amyloid Solution Inc | PCT App. | PCT/KR2019/016599 | 2019.11.28 |
| 5 | Composition for Treatment of Alzheimer's Disease comprising N402(Tentative) Activator as Active Ingredient | Amyloid Solution Inc | KR App. | Undisclosed | Undisclosed |
| 6 | Composition and method for treatment of amyloid cranial neuropathy | Amyloid Solution Inc | US App. |
Undisclosed | Undisclosed |
| 7 | Pharmaceutical composition for treatment of neurodegenerative brain disease comprising rifamycin or pharmaceutically acceptable salt thereof as an active ingredient | Amyloid Solution Inc | KR App. | undisclosed | undisclosed |
| 8 | Pharmaceutical composition for treatment of neurodegenerative brain disease comprising compound increasing amyloid-β phagocytosis of glia as an active ingredient |
Amyloid Solution Inc | KR App. | undisclosed | undisclosed |
| 9 | Pharmaceutical composition for treatment of neurodegenerative brain disease comprising N403(Tentative) as an active ingredient |
Amyloid Solution Inc | KR App. | undisclosed | undisclosed |
| 10 | Composition for Treatment of Alzheimer's Disease comprising N402(Tentative) Activator as Active Ingredient | Amyloid Solution Inc | PCT App. | Undisclosed | Undisclosed |